$946 Million is the total value of Rubric Capital Management LP's 52 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 175.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IGT | Buy | INTERNATIONAL GAME TECHNOLOG | $76,038,000 | +41.0% | 3,850,000 | +65.9% | 8.04% | +51.6% |
WMIH | Buy | WMIH CORP | $67,739,000 | +423.6% | 48,732,780 | +404.7% | 7.16% | +462.7% |
HRTX | Buy | HERON THERAPEUTICS INC | $61,998,000 | +40.0% | 1,958,850 | +71.8% | 6.55% | +50.5% |
INCY | New | INCYTE CORP | $54,894,000 | – | 794,640 | +100.0% | 5.80% | – |
GMS | Buy | GMS INC | $46,595,000 | -7.0% | 2,008,392 | +8.6% | 4.92% | -0.0% |
AVYA | Buy | AVAYA HLDGS CORP | $41,492,000 | +2690.3% | 1,874,060 | +2430.1% | 4.38% | +2902.7% |
FLXN | Buy | FLEXION THERAPEUTICS INC | $39,759,000 | -22.1% | 2,125,000 | +7.7% | 4.20% | -16.2% |
GPRE | New | GREEN PLAINS INC | $38,700,000 | – | 2,250,000 | +100.0% | 4.09% | – |
CSTM | Buy | CONSTELLIUM NVcl a | $29,738,000 | +24.5% | 2,407,958 | +3.8% | 3.14% | +33.8% |
CZR | New | CAESARS ENTMT CORP | $22,657,000 | – | 2,210,439 | +100.0% | 2.39% | – |
MBI | New | MBIA INC | $21,502,000 | – | 2,011,400 | +100.0% | 2.27% | – |
SMTA | Buy | SPIRIT MTA REIT | $21,215,000 | +25.8% | 1,841,587 | +12.4% | 2.24% | +35.2% |
PRTY | Buy | PARTY CITY HOLDCO INC | $20,393,000 | +9.2% | 1,505,000 | +22.9% | 2.16% | +17.4% |
BGCP | New | BGC PARTNERS INCcl a | $18,912,000 | – | 1,600,000 | +100.0% | 2.00% | – |
SD | Buy | SANDRIDGE ENERGY INC | $14,713,000 | -14.4% | 1,353,571 | +39.6% | 1.56% | -8.0% |
SATS | New | ECHOSTAR CORPcl a | $14,375,000 | – | 310,000 | +100.0% | 1.52% | – |
WYNN | New | WYNN RESORTS LTD | $13,977,000 | – | 110,000 | +100.0% | 1.48% | – |
SINA | New | SINA CORPord | $13,896,000 | – | 200,000 | +100.0% | 1.47% | – |
AMRN | New | AMARIN CORP PLCspons adr new | $11,389,000 | – | 700,000 | +100.0% | 1.20% | – |
MGY | New | MAGNOLIA OIL & GAS CORPcl a | $11,145,000 | – | 742,477 | +100.0% | 1.18% | – |
CHRS | Buy | COHERUS BIOSCIENCES INC | $10,395,000 | +117.4% | 630,000 | +84.5% | 1.10% | +133.6% |
FG | New | FGL HLDGS | $7,821,000 | – | 873,802 | +100.0% | 0.83% | – |
AGO | New | ASSURED GUARANTY LTD | $7,759,000 | – | 183,737 | +100.0% | 0.82% | – |
RDUS | New | RADIUS HEALTH INC | $4,935,000 | – | 277,260 | +100.0% | 0.52% | – |
MGM | New | MGM RESORTS INTERNATIONAL | $4,884,000 | – | 175,000 | +100.0% | 0.52% | – |
RVI | New | RETAIL VALUE INC | $3,328,000 | – | 101,790 | +100.0% | 0.35% | – |
EURN | New | EURONAV NV ANTWERPEN | $3,277,000 | – | 376,702 | +100.0% | 0.35% | – |
MACK | Buy | MERRIMACK PHARMACEUTICALS IN | $2,955,000 | +26.4% | 554,338 | +16.4% | 0.31% | +35.7% |
AKBA | New | AKEBIA THERAPEUTICS INC | $2,673,000 | – | 302,731 | +100.0% | 0.28% | – |
DHT | New | DHT HOLDINGS INC | $2,546,000 | – | 541,745 | +100.0% | 0.27% | – |
KERX | New | KERYX BIOPHARMACEUTICALS INC | $680,000 | – | 199,883 | +100.0% | 0.07% | – |
NAT | New | NORDIC AMERICAN TANKERS LIMI | $589,000 | – | 281,993 | +100.0% | 0.06% | – |
TK | New | TEEKAY CORPORATION | $529,000 | – | 78,442 | +100.0% | 0.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MAGNACHIP SEMICONDUCTOR CORP | 28 | Q3 2023 | 4.7% |
BGC PARTNERS INC | 20 | Q2 2023 | 4.6% |
MR COOPER GROUP INC | 20 | Q3 2023 | 5.9% |
PAR PACIFIC HOLDINGS INC | 18 | Q3 2023 | 3.9% |
RADIUS HEALTH INC | 16 | Q2 2022 | 4.3% |
CLEAR CHANNEL OUTDOOR HLDGS | 16 | Q3 2023 | 2.6% |
HERON THERAPEUTICS INC | 15 | Q3 2023 | 9.0% |
COLLEGIUM PHARMACEUTICAL INC | 15 | Q3 2023 | 3.9% |
AAR CORP | 14 | Q3 2023 | 3.2% |
GREEN PLAINS INC | 14 | Q3 2022 | 4.1% |
View Rubric Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Amryt Pharma plc | February 10, 2023 | 18,000,000 | 5.6% |
BGC Partners, Inc. | February 10, 2023 | 18,250,000 | 5.6% |
EverQuote, Inc. | February 10, 2023 | 1,246,622 | 4.8% |
Ferroglobe PLC | February 10, 2023 | 3,232,762 | 1.7% |
Sio Gene Therapies Inc. | February 10, 2023 | 7,000,000 | 9.5% |
Vincerx Pharma, Inc. | February 10, 2023 | 386,719 | 1.8% |
Whole Earth Brands, Inc. | February 10, 2023 | 998,363 | 2.4% |
Radius Health, Inc. | June 16, 2022 | 6,959,305 | 14.6% |
ANTARES PHARMA, INC. | February 14, 2022 | 10,800,000 | 6.4% |
Core Scientific, Inc./txSold out | February 14, 2022 | 0 | 0.0% |
View Rubric Capital Management LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2024-06-17 |
SC 13D/A | 2024-06-17 |
SC 13D/A | 2024-06-11 |
SC 13D/A | 2024-05-31 |
SC 13D/A | 2024-05-31 |
DFAN14A | 2024-05-16 |
13F-HR | 2024-05-10 |
DFAN14A | 2024-05-08 |
DFAN14A | 2024-05-03 |
DFAN14A | 2024-05-01 |
View Rubric Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.